NASDAQ: GOCO
Gohealth Inc Stock

$10.63-0.59 (-5.26%)
Updated Apr 21, 2025
GOCO Price
$10.63
Fair Value Price
N/A
Market Cap
$244.59M
52 Week Low
$7.27
52 Week High
$21.00
P/E
-16.11x
P/B
1.01x
P/S
0.17x
PEG
N/A
Dividend Yield
N/A
Revenue
$798.89M
Earnings
-$2.93M
Gross Margin
83.7%
Operating Margin
9.04%
Profit Margin
-0.4%
Debt to Equity
4.48
Operating Cash Flow
-$22M
Beta
1.3
Next Earnings
May 7, 2025
Ex-Dividend
N/A
Next Dividend
N/A

GOCO Overview

GoHealth, Inc. operates as a health insurance marketplace and Medicare focused digital health company in the United States. It operates through four segments: Medicare—Internal; Medicare—External; Individual and Family Plans (IFP) and Other—Internal; and IFP and Other—External. The company operates a technology platform that leverages machine-learning algorithms of insurance behavioral data to optimize the process for helping individuals find the health insurance plan for their specific needs. Its products include Medicare Advantage, Medicare Supplement, Medicare prescription drug plans, and Medicare Special Needs Plans; and IFP, dental plans, vision plans, and other ancillary plans to individuals. The company sells its products through carriers and online platform, as well as independent and external agencies. GoHealth, Inc. was founded in 2001 and is headquartered in Chicago, Illinois with additional offices in Charlotte, North Carolina, Lindon, Utah, Bratislava, Slovakia, and Kosice, Slovakia.

Zen Rating

Our proven quant model uses 115 proprietary factors, including AI, to determine GOCO's potential to beat the market

CHold
  • Stocks with a Zen Rating of Hold (C) had an average return of +7.53% per year. Learn More

Zen Rating Component Grades

C
Zen Rating uses advanced AI algorithms that detect subtle patterns in market data; it anticipates future trends that point to superior stock price results.

Industry: Insurance

Industry Rating
A
GOCO
Ranked
#6 of 14

Top Ranked Stocks in Industry

Name / TickerPriceZen Rating
$10.22A
$110.17B
$2.95B
View Top Insurance Stocks

Be the first to know about important GOCO news, forecast changes, insider trades & much more!

GOCO News

Overview

Due Diligence Score

Industry Average (34)
You've viewed Due Diligence Score for 10/10 free stocks. Upgrade to Premium to see how GOCO scored across 33 valuation, financial, forecast, performance, and dividend due diligence checks.

Due Diligence Checks

GOCO is unprofitable, so we are unable to calculate its intrinsic value according to an updated version of Benjamin Graham's Formula from "The Intelligent Investor"
Below Benjamin Graham Formula Value Valuation
GOCO is good value based on its book value relative to its share price (1.01x), compared to the US Insurance Brokers industry average (6x)
P/B vs Industry Valuation
GOCO is unprofitable, so we... subscribe to Premium to read more.
PEG Value Valuation
There are 30 more GOCO due diligence checks available for Premium users.

Valuation

GOCO price to earnings (PE)

For valuing profitable companies with steady earnings

Company
-16.11x
Industry
0.62x
Market
27.14x

GOCO price to book (PB)

For valuing companies that are loss-making or have lots of physical asset

Company
1.01x
Industry
6x
GOCO is good value based... subscribe to Premium to read more.
P/B vs Industry Valuation

GOCO's financial health

Profit margin

Revenue
$389.1M
Net Income
$25.5M
Profit Margin
6.6%
GOCO's cash burn is expected... subscribe to Premium to read more.
Interest Coverage Financials
GOCO's profit margin has increased... subscribe to Premium to read more.
Profit Margin Growth Financials

Assets to liabilities

Assets
$1.5B
Liabilities
$1.1B
Debt to equity
4.48
GOCO's short-term assets ($400.41M) exceed... subscribe to Premium to read more.
Short-term Liabilities Financials
GOCO's long-term liabilities ($744.93M) exceed... subscribe to Premium to read more.
Long-term Liabilities Financials
GOCO's debt has increased relative... subscribe to Premium to read more.
Shrinking Debt Financials
GOCO's debt to equity ratio... subscribe to Premium to read more.
Healthy Debt to Equity Financials

Cash flow

Operating
$14.6M
Investing
-$2.2M
Financing
-$7.0M
GOCO's cash and short-term investments... subscribe to Premium to read more.
Debt Coverage Financials

GOCO vs Insurance Stocks

TickerZen RatingMarket Cap1d %P/EP/B
GOCOC$244.59M-5.26%-16.11x1.01x
EHTHC$167.38M-5.57%-4.70x0.28x
ZBAO$32.69M+10.15%11.09x3.25x
HUIZ$18.36M+1.11%N/A0.04x
AIFU$6.83M+0.79%0.33x0.02x

Gohealth Stock FAQ

What is Gohealth's quote symbol?

(NASDAQ: GOCO) Gohealth trades on the NASDAQ under the ticker symbol GOCO. Gohealth stock quotes can also be displayed as NASDAQ: GOCO.

If you're new to stock investing, here's how to buy Gohealth stock.

What is the 52 week high and low for Gohealth (NASDAQ: GOCO)?

(NASDAQ: GOCO) Gohealth's 52-week high was $21.00, and its 52-week low was $7.27. It is currently -49.38% from its 52-week high and 46.22% from its 52-week low.

How much is Gohealth stock worth today?

(NASDAQ: GOCO) Gohealth currently has 23,009,065 outstanding shares. With Gohealth stock trading at $10.63 per share, the total value of Gohealth stock (market capitalization) is $244.59M.

Gohealth stock was originally listed at a price of $291.89 in Jul 15, 2020. If you had invested in Gohealth stock at $291.89, your return over the last 4 years would have been -96.36%, for an annualized return of -56.32% (not including any dividends or dividend reinvestments).

How much is Gohealth's stock price per share?

(NASDAQ: GOCO) Gohealth stock price per share is $10.63 today (as of Apr 21, 2025).

What is Gohealth's Market Cap?

(NASDAQ: GOCO) Gohealth's market cap is $244.59M, as of Apr 22, 2025.

Market cap (market capitalization) is the total market value of a publicly traded company's outstanding shares.

Gohealth's market cap is calculated by multiplying GOCO's current stock price of $10.63 by GOCO's total outstanding shares of 23,009,065.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.